Blister Pack Rules Delay Until 2026
- A planned government decision to end funding for pharmacy-provided medication blister packs has been postponed following meaningful public and political opposition.
- Medication blister packs organize daily doses of medication into separate compartments, helping patients - notably the elderly and those managing complex medication regimens or conditions like dementia -...
- Following "extensive engagement" between the Irish Pharmacy Union (IPU) and the Department of Health and the Health Service Executive (HSE), the introduction of charges has been paused until...
Blister Pack Charges Delayed to 2026 Following Public Concern
A planned government decision to end funding for pharmacy-provided medication blister packs has been postponed following meaningful public and political opposition. the initial policy,slated to take effect in January 2026,would have introduced fees of €20 to €50 per month for the service,raising concerns among vulnerable populations.
What are Medication Blister Packs?
Medication blister packs organize daily doses of medication into separate compartments, helping patients – notably the elderly and those managing complex medication regimens or conditions like dementia – avoid confusion regarding dosage and timing. They are designed to improve medication adherence and patient safety.
Charges Paused After Engagement
Following “extensive engagement” between the Irish Pharmacy Union (IPU) and the Department of Health and the Health Service Executive (HSE), the introduction of charges has been paused until a later date in the first quarter of 2026. This decision allows for further consultation and planning.
Clarification on Existing Services
The IPU emphasized that the supply of blister packs has historically been a private service,not reimbursed by the State,wiht pharmacies setting their own fees. This pause addresses concerns about a new financial burden on patients who rely on this service.
Future Engagement with Patients
Minister for Health Jennifer Carroll MacNeill expressed support for the outcome, stating that the delay will provide the IPU with additional time to engage with patients in a “structured and individualised way” over the next three months. This period will be crucial for ensuring a smooth transition and addressing patient needs.
